Top of the page.
Skip the menu to main contents.
Move to main menu.
Skip to main contents.

[Logo]FUJIFILM KYOWA KIRIN BIOLOGICS Co., Ltd.

Pipeline

Code name Generic Name Therapeutic area
(Major indications)
Development stage Status
Pre-clinical Phase 1 Phase 3 Application Approval
FKB327 Adalimumab
(fully human anti-TNF-α monoclonal antibody)
Immunology
(Rheumatoid arthritis, Plaque psoriasis, Crohn's disease)
Phase 3 global clinical stages in rheumatoid arthritis
The primary endpoint(ACR20) met the prespecified criteria in October 2016
FKB238 Bevacizumab
(humanized anti-VEGF monoclonal antibody)
Oncology
(Colorectal cancer, Non-small cell lung cancer, Cervical cancer)
Phase 3 global clinical stages in non-small cell lung cancer
Text Size

Pickup

  • Biosimilar
  • Solution
  • Message

Group Companies

  • FUJIFILM
  • KYOWA KIRIN

Back to Top